GDF-15 and the effect of empagliflozin in heart failure: findings from the EMPEROR Program

20 May 2023 (08:00 - 20:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Joao Pedro Ferreira

University of Porto, Porto (Portugal)

6 More presentations in this session

Presentation thumbnail

Predictors of spot urinary sodium in patients with acute decompensated heart failure: a sub analysis of the TAILOR-AHF randomized trial

Miss D. Hofman (Heerlen, NL)

Abstract Slides

Presentation thumbnail

Cardiac troponin t (cTnT) and n-terminal pro-B-type natriuretic peptides (NT-proBNP) for prediction of 30-day readmission or death in patients with acute dyspnea: data from the ACE2 study

Doctor R. Bhatnagar (Oslo, NO)

Abstract Slides

Presentation thumbnail

Predictive value of urinary spot sodium in acutely decompensated heart failure: results from the TAILOR-AHF observational study

Doctor M. Hoen (Heerlen, NL)

Abstract Slides

Presentation thumbnail

Predictive value of NT-proBNP in patients hospitalized for acute heart failure

Doctor A. Milovancev (Novi Sad, RS)

Abstract Slides

Presentation thumbnail

The source of liberation of dipeptidyl peptidase 3 (DPP3), a newly emerged cardiac biomarker, in pathological situations

Miss N. Assad (Paris, FR)

Abstract Slides

Access the full session

Session thumbnail

Acute heart failure - diagnostic methods

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023

You may be interested in

Congress Presentation

The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure

Congress Presentation

Novel concepts in the diagnosis of AHF in the emergency department

Congress Presentation

Growth differentiation factor 15 and absorption loss as new biomarkers of heart failure decompensation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources